EMJ Podcast: Insights For Healthcare Professionals

In this first deep dive, Spiegel unpacks his bold hypothesis: that irritable bowel syndrome and similar disorders could stem from gravity intolerance. He discusses his self-experiment simulating stronger gravity, the role of core strength in symptom relief, and how altitude affects gastrointestinal conditions.

Timestamps:01:04 – What is gravity intolerance?

02:55 – Gravity and chronic conditions

06:18 – Gravity and irritable bowel syndrome

09:29 – Self experiment

12:37 – Gravity's effect on pregnancy

16:43 – How should patients and clinicians think about gravity?

Brennan Spiegel answers rapid-fire questions about the effects of gravity on the human body and mind. From fatigue to irritable bowel syndrome to mental health, learn why gravity might be one of medicine's most overlooked forces, and how virtual reality is helping researchers study its effects.

In this episode of Hema Now, Diana Passaro from the Institut Cochin in Paris, France, shares her insights into tumour dissemination and the infiltration of the central nervous system by leukaemic cells. She discusses the mechanisms that regulate cell‑cell interactions within the microenvironment and how emerging tools like spatial transcriptomics are shaping the next generation of leukaemia research.

Timestamps:

00:00 – Introduction 01:15 – Origin of interest 03:30 – Influences on research 05:30 – Work highlights 07:09 – Leukaemia challenges 08:50 – Cell–microenvironment interaction 11:55 – Science at the interfaces 15:20 – Cross-disciplinary work 16:50 – Tumour spread context 19:50 – Innovations and technology 21:01 – Future of research 23:31 – Final takeaways

In this final episode, Ghatak and Olivo reflect on leadership, mentorship, and the legacy of innovation in diagnostics. Discover what drives them to keep pushing the boundaries of healthcare technology.

Timestamps:

00:00 - Introduction

00:45 - Good leadership

05:04 - Advice for young professionals

07:34 - Diagnostic gaps

09:34 - Maintaining motivation

10:33 - ImmunoProfile legacy

From lab to clinic, how do diagnostic breakthroughs make a real-world impact? Ghatak and Olivo explore bridging the gap between development and implementation, managing risk, and balancing innovation with ethics in patient care.

Timestamps:

00:00 – Introduction

00:43 – Implementation challenges

02:40 – Strategic risk

03:46 – Trial and error

06:21 – Ethical dilemmas

09:46 – Lessons learned

11:00 – Successful innovation

13:12 – 'Good' diagnostics

In this episode, Jonathan Sackier speaks with Brian Rini, Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA, and an internationally known leader in genitourinary oncology. The discussion explores the evolution of kidney cancer treatment, highlighting breakthroughs in immunotherapy, targeted therapy, and precision oncology. Rini shares insights from landmark clinical trials, his passion for translational research, and the challenges of broadening trial access. He also reflects on the future of the field, including the role of artificial intelligence, biomarker-driven strategies, and his hopes for advancing patient outcomes worldwide.

Timestamps:

00:00 – Introduction

01:10 – Key insights into kidney cancer

03:50 – Brian's career journey

07:40 – One piece of career advice

10:40 – Diagnosis of kidney cancer

12:04 – Treatment landscape for kidney cancer

17:00 – Landmark trials in renal cell carcinoma

19:18 – Precision-based approach in trial design and selection

23:40 – Translational research

26:35 – Clinical trial recruitment

30:25 – Diversity in kidney cancer research

32:27 – ESMO 2025 highlights

35:00 – Potential of AI in trial design and recruitment

36:43 – Uncovered areas for research

38:12 – Brian's three wishes for healthcare

In this EMJ podcast, experts discuss challenges within endometriosis care and cryoablation as an emerging treatment option. Navigating disease burden, current management limitations, the promise of precision imaging and minimally invasive techniques, the conversation highlights early clinical experience, ongoing research, and future directions for integrating cryoablation into endometriosis care.

How can clinicians make a difference? Woodruff outlines practical steps, screening tools, and advocacy approaches that can help reduce patients' exposure to harmful chemicals. She also reflects on policy progress and shares trusted resources for environmental health education.

Timestamps: 01:16 – Action and change

06:39 – How to reduce patients' toxic exposure

08:27 – Practical tools and screening

13:46 – Advocacy and policy

Which communities bear the brunt of pollution during pregnancy and early life? Woodruff explores the links between socioeconomic status, genetics, and environmental exposure, illustrating how 'double jeopardy' and environmental injustice compound health risks for vulnerable families.

Timestamps: 01:36 – Pre-term birth

06:07 – Gut microbiome

11:37 – Genetic factors

12:59 – Double jeopardy

14:26 – Environmental injustice

14:54 – Cancer valley

How is diagnostic innovation evolving across industries and institutions? In Part 1, Sudip Ghatak and Paul Olivo discuss the drivers of innovation, from scientific discovery to clinical need, and reveal the most disruptive changes happening in diagnostics today.

Timestamps: 00:00 – Introduction

02:16 – Unpacking ImmunoProfile

05:50 – Testing for who?

08:03 – Immunity studies

10:31 – Startups

12:00 – Diagnostic innovation

15:00 – Disruptive changes